Toshimori Koh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Toshimori Koh has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
A Yamaguchi
1 shared publicationH Katoh
1 shared publicationH Taniguchi
1 shared publicationH Yamagishi
1 shared publicationHiroki Taniguchi
Department of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
1 shared publicationHisakazu Yamagishi
Department of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
1 shared publication
Latest Publications
- 26 October 2002
- Vol. 49 (48) , 1615-8
Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
The aim of this study was to clarify the need for measuring of PIVKA-II (protein induced by vitamin K absence or antagonist-II) and alpha-fetoprotein as the prognostic indicator for patients after hepatic resection for hepatocellular carcinoma, and as the monitoring modality for early detection of recurrence after hepatic resection. One hundred and thirty-one patients who underwent planned liver resections for hepatocellular carcinoma were studied. The survival rates in patients positive for preoperative tumor markers were significantly lower than in those in the negative patients. The first modality leading to the diagnosis of recurrence was measurement of alpha-fetoprotein and/or PIVKA-II in 25 cases (55.6%). Almost all patients (96.6%) with positive preoperative alpha-fetoprotein and recurrence had elevated alpha-fetoprotein again when recurrence was found. Preoperative PIVKA-II and/or alpha-fetoprotein levels can predict postoperative prognosis. Measurement of these markers is useful in monitoring recurrence. For following up patients with alpha-fetoprotein-producing tumors, alpha-fetoprotein monitoring only is sufficient to detect recurrence.
- 26 October 2002
- Vol. 49 (48) , 1615-8
Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
The aim of this study was to clarify the need for measuring of PIVKA-II (protein induced by vitamin K absence or antagonist-II) and alpha-fetoprotein as the prognostic indicator for patients after hepatic resection for hepatocellular carcinoma, and as the monitoring modality for early detection of recurrence after hepatic resection. One hundred and thirty-one patients who underwent planned liver resections for hepatocellular carcinoma were studied. The survival rates in patients positive for preoperative tumor markers were significantly lower than in those in the negative patients. The first modality leading to the diagnosis of recurrence was measurement of alpha-fetoprotein and/or PIVKA-II in 25 cases (55.6%). Almost all patients (96.6%) with positive preoperative alpha-fetoprotein and recurrence had elevated alpha-fetoprotein again when recurrence was found. Preoperative PIVKA-II and/or alpha-fetoprotein levels can predict postoperative prognosis. Measurement of these markers is useful in monitoring recurrence. For following up patients with alpha-fetoprotein-producing tumors, alpha-fetoprotein monitoring only is sufficient to detect recurrence.
- 1 October 2000
- Published by Elsevier in Clinical Positron Imaging
- Vol. 3 (5) , 213-218
Possibility of Differential Diagnosis of Small Polypoid Lesions in the Gallbladder Using FDG-PET
- 1 October 2000
- Published by Elsevier in Clinical Positron Imaging
- Vol. 3 (5) , 213-218
Possibility of Differential Diagnosis of Small Polypoid Lesions in the Gallbladder Using FDG-PET